• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension.

出版信息

J Hum Hypertens. 1997 Jun;11(6):331-42. doi: 10.1038/sj.jhh.1000467.

DOI:10.1038/sj.jhh.1000467
PMID:9249226
Abstract
摘要

相似文献

1
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension.
J Hum Hypertens. 1997 Jun;11(6):331-42. doi: 10.1038/sj.jhh.1000467.
2
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension.钙拮抗剂对冠心病、癌症及出血风险的影响。世界卫生组织与国际高血压学会联络委员会特设小组委员会。
J Hypertens. 1997 Feb;15(2):105-15.
3
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension.钙拮抗剂对冠心病、癌症及出血风险的影响。世界卫生组织与国际高血压学会联络委员会特设小组委员会
Hypertens Res. 1997 Jun;20(2):61-73.
4
Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. Ad hoc subcommittee of the Liaison Committee of the World Health Organisation and the International Society of Hypertension.钙拮抗剂对冠心病、癌症及出血风险的影响。世界卫生组织与国际高血压学会联络委员会特设小组委员会
Blood Press. 1997 May;6(3):134-46. doi: 10.3109/08037059709061929.
5
Clinical implications of the World Health Organization-International Society of Hypertension statement on calcium antagonists.世界卫生组织 - 国际高血压学会关于钙拮抗剂声明的临床意义
J Hypertens. 1997 Nov;15(11):1197-200. doi: 10.1097/00004872-199715110-00001.
6
Calcium antagonists, is there a real concern about safety?钙拮抗剂，真的存在安全性问题吗？
Acta Clin Belg. 1998 Apr;53(2):61-5. doi: 10.1080/17843286.1998.11754144.
7
Diabetes and risk of adverse events with calcium antagonists.糖尿病与钙拮抗剂相关不良事件的风险
Diabetes Care. 1998 Jan;21(1):193-4. doi: 10.2337/diacare.21.1.193.
8
Reliable and unbiased assessment of the effects of calcium antagonists: importance of minimizing both systematic and random errors.钙拮抗剂疗效的可靠且无偏倚评估：尽量减少系统误差和随机误差的重要性。
J Hypertens. 1997 Nov;15(11):1201-4. doi: 10.1097/00004872-199715110-00002.
9
Calcium channel blockers, risk of cancer, and the challenge of assessing medication safety.钙通道阻滞剂、癌症风险以及评估药物安全性的挑战。
Tenn Med. 1997 Sep;90(9):367-9.
10
Do calcium antagonists cause death, gastrointestinal bleeding, and cancer?钙拮抗剂会导致死亡、胃肠道出血和癌症吗？
Am J Cardiol. 1996 Oct 15;78(8):932-3. doi: 10.1016/s0002-9149(96)00593-0.

引用本文的文献

1
Clinical implications of the 2013 ESH/ESC hypertension guidelines: targets, choice of therapy, and blood pressure monitoring.2013年欧洲高血压学会/欧洲心脏病学会高血压指南的临床意义：治疗目标、治疗选择及血压监测
Drugs R D. 2014 Jun;14(2):31-43. doi: 10.1007/s40268-014-0049-5.
2
Current treatment of patients with hypertension: therapeutic implications of INSIGHT.高血压患者的当前治疗：国际硝苯地平控释片治疗高血压干预研究（INSIGHT）的治疗意义
Drugs. 2003;63(14):1435-44. doi: 10.2165/00003495-200363140-00001.
3
Calcium channel blockers. The jury is still out on whether they cause heart attacks and suicide.
钙通道阻滞剂。它们是否会引发心脏病和自杀，尚无定论。
BMJ. 1998 May 16;316(7143):1471-3. doi: 10.1136/bmj.316.7143.1471.